← Back

Herbalife Nutrition Ltd

Herbalife Ltd., together with its subsidiaries, provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers weight management products, including meal replacement, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products comprising functional beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness products; and facial skin care, body care, and hair care products. The company also provides literature, promotional, and other materials, such as start-up kits, sales tools, and educational materials. It sells its products through sales representatives, independent service providers, and company-operated retail stores and platforms. The company was formerly known as Herbalife Nutrition Ltd. and changed its name to Herbalife Ltd. in April 2023. Herbalife Ltd. was founded in 1980 and is headquartered in Los Angeles, California.

Price · split & dividend adjusted
News & notes moving HLF
HLF

Herbalife Q2 revenue beats but guidance disappoints among personal care peers

Herbalife reported second-quarter revenue of $1.33 billion, up 5.4% year over year and 1.5% above analyst expectations, but delivered the weakest guidance update among nine tracked personal care stocks. The group as a whole beat revenue consensus by 1.7% and guided next quarter 1.5% above estimates, yet shares have fallen 5.7% on average since reporting. e.l.f. Beauty posted the strongest results with revenue of $479.4 million, up 35.5% and 11% above estimates, while Nature's Sunshine was the weakest with revenue of $117 million, up 1.9% but 5.4% below expectations. Herbalife shares are down 3% since reporting and trade at $12.23.
Yahoo Finance·5dRead more ▾
HLF

Herbalife projects full-year 2026 adjusted EBITDA of $670M-$690M and announces CFO transition for 2027

Herbalife Ltd. outlined full-year 2026 adjusted EBITDA guidance of $670 million to $690 million on a reported basis while announcing that CFO John DeSimone will retire at year-end and be succeeded by Scott Schaefer at the start of 2027. Second-quarter net sales rose 5.4% to $1.3 billion, at the top end of guidance, and adjusted EBITDA reached $167 million, also at the high end of its range. The company narrowed its full-year net sales growth outlook to 2.5% to 5.5% on both a reported and constant currency basis, and it still targets a net leverage ratio below 2x by year-end. The quarter included a GAAP net loss of $26 million driven by a nearly $95 million pretax loss on debt extinguishment, while operating cash flow for the first half of 2026 jumped 52% to $147 million. Management highlighted the launch of Bioniq Go personalized supplements and the continued beta expansion of the Pro2col platform as key strategic milestones.
Seeking Alpha·21dRead more ▾
HLF

Herbalife Q2 earnings miss estimates

Herbalife Ltd reported second-quarter earnings of $0.51 per share, missing the Zacks Consensus Estimate of $0.63 per share and marking a negative earnings surprise of 19.05%. Revenue came in at $1.33 billion, topping the consensus estimate by 2.06% and up from $1.26 billion a year ago. The company has beaten EPS estimates twice in the last four quarters but has exceeded revenue estimates only once in that span. Shares have lost about 0.7% year to date, underperforming the S&P 500's 13% gain. The current Zacks Rank for Herbalife is #3 (Hold), with consensus estimates for the coming quarter at $0.70 per share on $1.3 billion in revenue and for the fiscal year at $2.68 per share on $5.2 billion in revenue.
Zacks Investment Research·21dRead more ▾
HLF

Herbalife Survey Finds 82% of Asia Pacific Consumers Prioritize Holistic Health

A new Herbalife survey reveals that four in five consumers across Asia Pacific now consider holistic health very or extremely important, with 74% saying it matters more than three years ago. The Herbalife APAC Wellness Culture Survey 2026, which polled over 10,000 respondents in 11 markets including Australia, Hong Kong SAR, Indonesia, Japan, Korea, Malaysia, Philippines, Singapore, Taiwan region, Thailand and Vietnam, found that 44% want to improve sleep quality, 38% seek better mental wellbeing and stress management, 31% aim to enhance nutrition quality, and 30% focus on weight management. Top factors driving the trend include aging at 46%, personal health scares at 42%, growing awareness of wellness trends at 32%, and a desire to invest in long-term health at 31%. Around 58% of respondents increased both the variety and frequency of wellness activities compared to three years ago, with regular exercise, healthier food choices, improved sleep habits, and supplement use among the most common practices. Despite this progress, only two in five say their current physical, mental and emotional health is better than three years ago, citing lack of time and motivation as key challenges, while many look to family, friends, and social media for greater support.
PR Newswire·29dRead more ▾
HLF2

Personal care stocks post strong Q1 with revenues beating estimates by 2.5%

The nine personal care stocks tracked by the report delivered a strong first quarter, with aggregate revenues beating analysts' consensus estimates by 2.5% while next quarter's revenue guidance came in 3.5% below expectations. Edgewell Personal Care reported flat revenues of $519.5 million, in line with estimates, and posted a very strong quarter with beats on EBITDA and organic revenue. USANA Health Sciences was the best performer, with revenues of $250.2 million exceeding expectations by 3.8% and solid beats on EBITDA and EPS. Herbalife was the weakest, with revenues of $1.32 billion up 7.8% year on year but next quarter EBITDA guidance missing estimates. Medifast reported revenues of $76.04 million, down 34.3% year on year, yet beat expectations by 9.9% and raised full-year guidance. Estée Lauder posted revenues of $3.71 billion, up 4.6% year on year, in line with estimates, and exceeded EPS expectations while raising full-year EPS guidance. Share prices of the group have risen 11.7% on average since the latest earnings results.
Yahoo Finance·36dRead more ▾
Aging Population

Advanced Therapeutics Aging and Wellness Market to Reach $275.35 Billion by 2035

The global advanced therapeutics market for aging and wellness is projected to grow from $154.89 billion in 2024 to $275.35 billion by 2035, at a compound annual growth rate of 5.51%. The functional nutrition segment held the largest share by product type in 2024, while energy, endurance, and active aging led among application types, and retail dominated distribution channels. North America accounted for the largest regional share, driven by a developed healthcare ecosystem and high consumer awareness. Key players include Abbott, Amway, and Nestlé, with recent developments such as Amway's 2.1 billion yuan investment plan in China and Orgain's launch of a plant-based protein powder with metabolism support.
ResearchAndMarkets.com·47dRead more ▾
Synthetic Biology (non-pharma)

Herbalife and IIT Madras Launch India's First Centre of Excellence on Plant Cell Fermentation Technology

Herbalife and IIT Madras have inaugurated India's first dedicated facility for translational research in plant cell fermentation technology. The Herbalife–IIT Madras Centre of Excellence, launched on 22nd June 2026 at IIT Madras Research Park, aims to position India as a global leader in sustainable biomanufacturing and next-generation plant-derived health and wellness products. The centre will focus on scalable production of herbal biomass, development of enriched extracts and high-value phytochemicals, and bridging the gap between lab discoveries and industrial applications. It is equipped with customized plant cell bioreactors, advanced analytical platforms, and pilot-scale processing facilities. The initiative aligns with India's BioE3 and Atmanirbhar Bharat missions and is expected to foster academia-industry collaborations, intellectual property generation, and entrepreneurship.
PRNewswire·62dRead more ▾
HLF

Herbalife Stock Drops 14.3% Over Six Months Amid Mixed Signals

Herbalife's stock price fell to $12.16 over the past six months, a 14.3% decline that contrasts with the S&P 500's 7.8% gain. The company maintains an elite 86% gross margin and a five-year average return on invested capital of 50.8%, signaling strong unit economics and capital efficiency. However, organic revenue growth has been feeble, averaging just 1.1% year-on-year over the last eight quarters, raising concerns about waning demand in its core business. The stock now trades at 4.4 times forward price-to-earnings.
Yahoo Finance·63dRead more ▾